Back
Mersana Therapeutics Vs. Anavex Life Sciences Industry Stock Comparison
Sell
4
MRSN
Mersana Therapeutics
Last Price:
1.45
Seasonality Move:
-13.32%
Buy
75
AVXL
Anavex Life Sciences
Last Price:
6.33
Seasonality Move:
6.69%
Sell
4
Mersana Therapeutics (MRSN)
is a Sell
Is Mersana Therapeutics a Buy, Sell or Hold?
- The current Mersana Therapeutics [MRSN] share price is $1.46. The Score for MRSN is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- MRSN is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
75
Anavex Life Sciences (AVXL)
is a Buy
Is Anavex Life Sciences a Buy, Sell or Hold?
- The current Anavex Life Sciences [AVXL] share price is $6.64. The Score for AVXL is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- AVXL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MRSN Stock Price Chart
What is Mersana Therapeutics's stock price today?
-
The Mersana Therapeutics share price today is $1.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRSN is experiencing slight selling pressure.
AVXL Stock Price Chart
What is Anavex Life Sciences's stock price today?
-
The Anavex Life Sciences share price today is $6.64
The current trend is moderately bullish and AVXL is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRSN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 28.15 | Sell |
| Chaikin Money Flow: | -51182 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.7 - 2.16) | Sell |
| Bollinger Bands (100): | (1.85 - 3.71) | Sell |
AVXL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.47 | Buy |
| Relative Strength Index (14 RSI): | 59.19 | Buy |
| Chaikin Money Flow: | 578157 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.13 - 6.77) | Buy |
| Bollinger Bands (100): | (3.65 - 5.55) | Buy |
MRSN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.68 | Sell |
| 20-day SMA: | 1.93 | Sell |
| 50-day SMA: | 2.03 | Sell |
| 200-day SMA: | 2.79 | Sell |
| 8-day EMA: | 1.64 | Sell |
| 20-day EMA: | 1.83 | Sell |
| 50-day EMA: | 2.12 | Sell |
| 200-day EMA: | 2.84 | Sell |
AVXL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.52 | Buy |
| 20-day SMA: | 6.29 | Buy |
| 50-day SMA: | 4.97 | Buy |
| 200-day SMA: | 5.51 | Buy |
| 8-day EMA: | 6.5 | Buy |
| 20-day EMA: | 6.14 | Buy |
| 50-day EMA: | 5.4 | Buy |
| 200-day EMA: | 5.61 | Buy |
Mersana Therapeutics Earnings Growth & MRSN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.01 per share, an increase this year of $0.78 per share, and a decrease next year of $0.05 per share.
Anavex Life Sciences Earnings Growth & AVXL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.09 per share, and a decrease next year of $0.25 per share.
Mersana Therapeutics Technical Analysis
| Jul 26 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 2 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 26 | 29 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Anavex Life Sciences Technical Analysis
| Jul 26 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 2 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | Aug | |||||||||
| 26 | 29 | 30 | 31 | 01 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||